Work

Faculty Opinions recommendation of Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.

Year: 2008

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.1122822.579910

Authors: Keith Flaherty, Stephen Keefe

Institutions: Massachusetts General Hospital, University of Pennsylvania

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4212839121

Cites:

Cited by:

Related to: 10